Brief: Serina Therapeutics Appoints Dr. Simba Gill As Executive Chairman
17/04/2024 22:38
April 17 (Reuters) - Serina Therapeutics Inc SER.A :
* SERINA THERAPEUTICS APPOINTS DR. SIMBA GILL AS EXECUTIVE
CHAIRMAN
Source text for Eikon: ID:nGNXb1dHRx
Further company coverage: SER.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Serina Therapeutics
See all newsBrief: Serina Therapeutics Inc Reports Cohort 1 Observations From Ser-252 Registrational Study In Advanced Parkinson’S Disease And Advances To Cohort 2
Brief: Serina Therapeutics - Offers Up To 12,500,000 Shares Of Common Stock By Roth Principal Investments - SEC Filing
Serina Therapeutics Q2 net loss widens on higher expenses
Brief: Serina Therapeutics Appoints Farrell Simon To Its Board Of Directors
Brief: Serina Therapeutics Completes Sentinel Dosing In Cohort 1 Of Phase 1B Registrational Trial Of SER-252